Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Karl-Heinz Braunewell, PhD
Drug discovery for the neuronal calcium sensor (NCS) protein VILIP-1 as possible target for cognitive impairment in CNS disorders
A GuideStar-Rated Charity
© Copyright 2025. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).